Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3, 4-methylenedioxymethamphetamine

Axt, 1990, α-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation, Brain Res., 515, 269, 10.1016/0006-8993(90)90606-C

Battaglia, 1991, Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3, 4-methyl-enedioxymethamphetamine): assessment using quantitative autoradiography, Synapse, 8, 249, 10.1002/syn.890080403

Bowyer, 1991, Interactions of MK-801 with glutamate-, glutamine- and methamphetamine-evoked release of [3H]dopamine from striatal slices, J. Pharmacol. Exp. Ther., 257, 262

Chapman, 1989, Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres, Neurosci. Lett., 107, 256, 10.1016/0304-3940(89)90827-6

Clow, 1988, Characterization ofl-glutamate action on the release of endogenous dopamine from the rat caudate-putamen, J. Pharmacol. Exp. Ther., 248, 722

Donzanti, 1988, An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates, Life Sci., 43, 913, 10.1016/0024-3205(88)90267-6

Filloux, 1991, Dopaminergic modulation of excitotoxicity in rat striatum: evidence from nigrostriatal lesions, Synapse, 8, 281, 10.1002/syn.890080406

Finnegan, 1990, TheN-methyl-d-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3, 4-methylenedioxymethamphetamine (MDMA) in rats, Neurosci. lett., 105, 300, 10.1016/0304-3940(89)90637-X

Godhukin, 1984, Role of presynaptic dopamine receptors in regulation of the glutamatergic neurotransmission in rat neostriatum, Neuroscience, 12, 377, 10.1016/0306-4522(84)90059-9

Hotchkiss, 1980, Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain, J. Pharmacol. Exp. Ther., 214, 257

Hotchkiss, 1979, The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyl-transferase and glutamate decar☐ylase activities, Life Sci., 25, 1373, 10.1016/0024-3205(79)90414-4

Insel, 1989, 3, 4-Methylenedioxymethamphetamine (‘Ecstasy’) selectively destroys brain serotonin terminals in Rhesus monkeys, J. Pharmacol. Exp. Ther., 249, 713

Johnson, 1989, Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog, Eur. J. Pharmacol., 165, 315, 10.1016/0014-2999(89)90728-0

Kleven, 1989, Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys, Brain Res., 488, 121, 10.1016/0006-8993(89)90700-2

Kovachich, 1989, Effects of high-dose methamphetamine administration on serotonin uptake sites in rat brain measured using [3H]cyanoimipramine autoradiography, Brain Res., 505, 123, 10.1016/0006-8993(89)90122-4

Krebs, 1991, Glutamatergic control of dopamine release in the rat striatum: evidence for presynapticN-methyl-d-aspartate receptors on dopaminergic nerve terminals, J. Neurochemistry, 56, 81, 10.1111/j.1471-4159.1991.tb02565.x

Marek, 1990, The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat, Brain Res., 516, 1, 10.1016/0006-8993(90)90889-J

Marek, 1990, Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats, Pharmacol. Biochem. Behav., 36, 187, 10.1016/0091-3057(90)90147-A

Maura, 1988, Release-regulatingd-2 dopamine receptors are located on striatal glutamatergic nerve terminals, J. Pharmacol. Exp. Ther., 247, 680

Maura, 1988, Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors, Eur. J. Pharmacol., 145, 31, 10.1016/0014-2999(88)90345-7

McKenna, 1990, Neurochemistry and neurotoxicity of 3, 4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), J. Neurochem., 54, 14, 10.1111/j.1471-4159.1990.tb13277.x

Nash, 1990, Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis, Life Sci., 47, 2401, 10.1016/0024-3205(90)90484-9

Nash, 1991, Effect of 3, 4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats, Biochem. Pharmacol., 41, 79, 10.1016/0006-2952(91)90013-U

Nash, 1990, Effect of 3, 4-methylenedioxymethamphetamine on 3, 4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens, J. Neurochem., 54, 1062, 10.1111/j.1471-4159.1990.tb02358.x

Nash, 1991, Microdialysis studies on 3, 4-methylenedioxyamphetamine (MDA) and structurally related analogues, Eur. J. Pharmacol., 200, 53, 10.1016/0014-2999(91)90664-C

O'Hearn, 1988, Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity, J. Neurosci., 8, 2788, 10.1523/JNEUROSCI.08-08-02788.1988

Olney, J.W., Excitotoxic amino acids and neuropsychiatric disorders, Annu. Rev. Pharmacol. Toxicol., 30 (199) 47–71.

Paxinos, 1986

Raiteri, 1986, Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum, J. Pharmacol. Exp. Ther., 237, 644

Ricaurte, 1988, Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration, Brain Res., 446, 165, 10.1016/0006-8993(88)91309-1

Roberts, 1979, Stimulatory effect ofl-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions, J. Neurochem., 32, 1539, 10.1111/j.1471-4159.1979.tb11096.x

Robinson, 1987, Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application, FASEB J., 1, 446, 10.1096/fasebj.1.6.2890549

Rowlands, 1980, Activation of dopamine receptors inhibits calcium-dependent glutamate release from corticostriatal terminals in vitro, Eur. J. Pharmacol., 62, 241, 10.1016/0014-2999(80)90285-X

Schmidt, 1987, Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine, J. Pharmacol. Exp. Ther., 240, 1

Schmidt, 1985, Role of dopamine in the neurotoxic effects of methamphetamine, J. Pharmacol. Exp. Ther., 233, 539

Seiden, 1987, Neurotoxicity of methamphetamine and related drugs, 359

Seiden, 1984, Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine, Pharmacol. Biochem. Behav., 21, 29, 10.1016/0091-3057(84)90125-4

Shimizu, 1990, Glutamate modulates dopamine release in the striatum as measured by brain microdialysis, Brain Res. Bull., 25, 99, 10.1016/0361-9230(90)90258-2

Sonsalla, 1989, Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity, Science, 243, 398, 10.1126/science.2563176

Stone, 1988, NMDA receptors and ligands in the vertebrate CNS, Prog. Neurobiol., 30, 333, 10.1016/0301-0082(88)90027-5

Stone, 1988, Role of endogenous dopamine in the central serotonergic deficits induced by 3, 4-methylenedioxymethamphetamine, J. Pharmacol. Exp. Ther., 247, 79

Weihmuller, 1991, MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study, Brain Res., 549, 230, 10.1016/0006-8993(91)90462-5

Yamamoto, 1990, A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis, Brain Res., 506, 236, 10.1016/0006-8993(90)91256-G

Yamamoto, 1988, The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat, Eur. J. Pharmacol., 148, 195, 10.1016/0014-2999(88)90564-X

Yamamoto, 1992, Dopaminergic modulation of glutamate release in striatum as measured by microdialysis, J. Neurochem., 10.1111/j.1471-4159.1992.tb10048.x